Contact your GP or NHS 111 for persistent nausea, injection-site infection, or any other concerning symptoms, and bring the vial and packaging with you
Euglycemic diabetic ketoacidosis (EDKA) is a rare but potentially life-threatening condition that presents with metabolic acidosis and ketonemia in the absence of hyperglycemia
Notably, studies underscore the substantial impact of dietary choices on T2D predisposition
Early Phase Possible appetite or fullness changes Digestive adjustment Possible nausea or bloating Response varies by dose and individual tolerance First Few Weeks Some patients may notice appetite changes Eating patterns may begin to shift Energy and blood sugar response may vary Digestive adjustment may continue Provider follow-up helps guide next steps Ongoing Early Treatment Some patients may begin noticing weight-related changes Portion sizes may change Appetite patterns may continue adjusting Side effects may improve or require provider guidance Progress depends on the individual treatment plan Continued Provider Monitoring Provider reviews response and tolerance Weight-related progress may vary Appetite patterns may continue changing Lifestyle habits may support progress Dose or care plan may be adjusted if appropriate Longer-Term Follow-Up Ongoing progress varies by patient Provider may review labs, tolerance, and treatment response Lifestyle habits may support long-term weight management Treatment may continue, change, or stop based on clinical review What Affects How Fast You See Results
What do you and other organizations need to help you better serve your clients/trafficking clients (probe for training, legislation, funding/resources, etc.) Promising Practices Of the services you provide (or coordinate) for clients/trafficking clients, which would you describe as most effective in meeting client/trafficking client needs
For some GLP-1 users, there is an unexpected side effect bad breath, which is behind the increase in breath freshener sales
